Filing Flows › Ligand Pharmaceuticals (LGND) › Net income
Ligand Pharmaceuticals (LGND) net income by quarter
Ligand Pharmaceuticals' net income was $48.5M in Q2 2026 (second quarter 2026), +8% from Q4 2025. Over the last 4 quarters it ranged from $4.8M (Q2 2025) to $117M (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $48.5M | +8% | +901% |
| Q4 2025 | $44.8M | -62% | — |
| Q3 2025 | $117M | 24× | — |
| Q2 2025 | $4.8M | — | — |
Q2 2026 at a glance
Ligand Pharmaceuticals, Q2 2026: revenue $63.7M (+34% year over year), operating margin 13.5%, net earnings $48.5M, operating cash flow $24.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ligand Pharmaceuticals' net income?
Ligand Pharmaceuticals' net income was $48.5M in Q2 2026 (second quarter 2026), +8% from Q4 2025.
How has Ligand Pharmaceuticals' net income changed?
Over the last 4 quarters it ranged from $4.8M (Q2 2025) to $117M (Q3 2025).
Q2 2026 results → · How Ligand Pharmaceuticals makes money →